|
Wednesday 12th April 2023 |
Text too small? |
Chorus has today been advised by the Crown that UniSuper Limited have been granted approval, should they choose to exercise it in the future, to acquire a relevant interest in up to 20% of Chorus shares.
Under Chorus’ constitution, Crown approval is required if a shareholder wishes to have the option of holding 10% or more of Chorus shares.
ENDS
For further information:
Nathan Beaumont
Head of Corporate Relations
Phone: +64 4 896 4352
Mobile: +64 (21) 243 8412
Email: nathan.beaumont@chorus.co.nz
Brett Jackson
Investor Relations Manager
Phone: +64 4 896 4039
Mobile: +64 (27) 488 7808
Email: brett.jackson@chorus.co.nz
No comments yet
RAK - 1H26: Strong first half growth and strategic momentum
Green Cross Health Interim Results to 30 September 2025
Devon Funds Morning Note - 28 November 2025
November 28th Morning Report
Pacific Edge Appoints Chief Commercial Officer
Ryman Healthcare reports 1H26 results
Tower reports record FY25 result, increased dividends
NZ King Salmon Investments Ltd releases FY25 (Sept) results
RBNZ - OCR lowered to 2.25%
SVR - Savor Interim Results and Trading Update